This bias is reinforced by the marketing message of pharmaceutical companies to physicians, which has emphasized research on delayed diagnosis and under-recognition of bipolar disorder, possibly sensitizing clinicians accordingly. The campaign against under-recognition has probably resulted in some anxious, agitated, and/or irritable depressed patients who complain of insomnia and “racing thoughts” being misdiagnosed with bipolar disorder.
这种倾向被制药公司发送给医师们的营销信息强化了。这些信息强调对双相障碍诊断延误和认识不足的研究，就有可能使医师们变得敏感。针对认识不足的行动很可能造成一些抑郁病人被误诊为双相障碍。这些病人往往焦虑、不安和/或易怒，并抱怨有失眠和“思绪澎湃”的症状。